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Synthesis and antimicrobial activity of pyrazole derivatives via  
1,3-dipolar cycloaddition of nitrile imines with ethyl acetoacetate 
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The ethyl acetoacetate reacts with the nitrile imines generated in situ by the catalytic dehydrogenation of diphenyl 
hydrazones using chloramine-T (CAT) to afford regioselective cycloadducts in 80% yields respectively. The structures 
of these compounds have been characterized by FT-IR, 1H NMR, 13C NMR and mass spectroscopic techniques and 
elemental analysis. All the pyrazole derivatives have been tested for their antibacterial and antifungal activities. 
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INTRODUCTION 
Heterocyclic compounds are considered as the 
most promising molecules for the design of new 
drugs. 1,3-Dipolar cycloaddition reactions are an 
efficient synthetic tool for constructing biologically 
potent five membered heterocyclic compounds [1, 
2]. Pyrazoles, pyrazolines, pyrazolidines and pyra-
zolones are gaining importances as biologically 
active compounds possessing such as analgesic, 
antipyretic, antiinflammatory, germicidal and anti-
fungal activities [3, 4], antiprotozoal [5], fungicidal 
[6], bactericidal [6], herbicidal and plant growth 
regulating properties. 
Apart from the various dipolar reagent nitrile 
imines are used in numerous 1,3-dipolar cyclo-
addition reaction leading to pyrazoles, pyrazolines, 
pyrazolidines and other heterocyclic compounds [7]. 
Huisgen and co-workers first reported [8] the 
authentic in situ generation of nitrile imines by the 
thermolysis of 2,5-diphenyl tetrazole in the presence 
of ethyl phenyl propiolate and obtained 2,3,5-tri-
phenyl carbethoxypyrazole. The usual synthesis of 
nitrile imines involves the thermolysis or photolysis 
of tetrazole [8], oxidation of aldehyde hydrazones 
with lead tetra acetate [9], CAT [10] and mercuric 
acetate [11]. 
In addition to this, nitrile imines are known to 
react with heterocyclic compounds to yield a variety 
of polyheterocycles [12]. Shawali and co-workers 
[13] prepared a numerous pyrazole derivatives by 
the reaction of in situ generated nitrile imines 
obtained from hydrazidoyl halides with sodium salt 
of active methylene compounds, such as β-keto-
sulphones, β-ketoanilides and β-cyanoketones. 
Baruah et al. [14] generated the C-acetyl and C-
ethoxycarbonyl nitrile imines in situ from the cor-
responding hydrazonoyl halides in the presence of 
dry triethylamine in anhydrous chloroform, and 
have used these nitrile imines for the preparation of 
pyrazoles derivatives. The intramolecular cycload-
dition of in situ generated nitrile imine with aldo-
nitrones afforded triazoles [15]. Mogilaiah et al. 
[16] developed a solvent free method for the facile 
synthesis of 1,8-naphthyridinyl-pyrazoles using 
POCl3-DMF (Vilsmeier-Haack reagent) over silica 
gel under microwave irradiation. Aly et al. [17] 
showed a new synthetic route for the synthesis of 
some pyrazole derivatives from 3-aryl-1-phenyl-1H-
pyrazole-4-carbaldehydes. 
Padmavathi and co-workers [18] prepared acti-
vated bis pyrazolines and bis isoxazolines by 1,3-
dipolar cycloaddition of nitrile imines and nitrile 
oxides to activated bis olefinic systems in the 
presence of Chloramine-T. Bacchetti [19] prepared 
1,4-dicarboethoxy pyrazoles by intermolecular 
cycloaddition of nitrile imines with ethyl aceto-
acetate. Though there are more references available 
in the literature on cycloaddition of nitrile imines 
with alkenes and alkyne, there is a less information 
about the use of keto-enol tautomers as dienophile 
for the cycloaddition. We have synthesized [20] the 
1-(5-methyl-1,3-diphenyl-1H-pyrazol-4-yl)-ethanone 
in quantitative yield via 1,3-dipolar cycloaddition of 
enol form of acetyl acetone with the nitrile imines 
generated in situ by the catalytic dehydrogenation of 
diphenyl hydrazones using CAT. This prompted us 
to work in this area in detail to make it as a general 
method for the synthesis of pyrazoles derivatives. 
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RESULTS AND DISCUSSION 
It is well known that acetyl acetone and ethyl 
acetoacetate exist in two dynamic equilibrium states 
via, keto and enol forms. It is also known that 
typical cycloaddition of nitrile imines with alkenes 
and alkynes afford pyrazolines and pyrazoles 
respectively. It is interesting to note that, though the 
expected products are pyrazolines as similar to that 
of addition of nitrile imines to alkenes, the reaction 
afforded pyrazoles with loss of water molecule 
(Scheme). 
In typical reaction, a mixture of aldehyde hydra-
zone 1a with excess of ethyl acetoacetate 3 and 
CAT in glacial acetic acid was stirred at room 
temperature for about 2–3 hours. After the usual 
work up, 5a was isolated as light yellow oil in 80% 
yield. In similar manner, 1b–g were converted into 
the corresponding pyrazole derivatives 5b–g in good 
yields. IR, 1H NMR, 13C NMR, MS studies and 
elemental analysis provide the structural proof for 
the products. In 1H NMR spectra, the signals for the 
ethoxy protons appears as a quartet in the region δ 
4.12–4.31 ppm, (2H, J = 7.2 Hz, –OCH2–CH3), 
while the protons for the methyl group at C-5 appear 
as a singlet in the region δ 2.68–2.75 ppm. The 
downward shift of the methyl group at the C-5 is 
probably due to deshielding by the –CO–OC2H5 
group. These observations clearly indicate that the 
formation of the cycloadduct 5a is obtained via 
pyrazolines 4 with the loss of water molecule. In 13C 
NMR spectra, the –C-3 and C-4 appear as singlet 
(decoupled) in the region δ 160.82–161.14 and δ 
108.32–118.86 ppm respectively, C-5 appear as 
singlet in the region δ 176.14–176.26 ppm. All 
cycloadducts showed M+1 as a base peak in the 
mass spectra. Further, the elemental analysis sup-
ported the formation of the products. 
ANTIMICROBIAL SCREENING 
Synthesized pyrazoles (5a–g) were screened 
(dose of 100 µg) for their antibacterial activity 
against Gram-negative bacteria Escherichia coli (E. 
coli) and Gram-positive bacteria Staphylococcus 
aureus (S. aureus) using filter paper disc method 
[21]. Plates inoculated with E. coli were incubated 
for 48 h and plates inoculated with S. aureus for 24 
h respectively at room temperature. Streptomycin 
sulphate was used as a standard. After the period of 
incubation the inhibition zones were measured in 
mm and results obtained are shown in Table 1. All 
the compounds were also screened (dose of 100 µg) 
for their antifungal activity against Candida albi-
cans (C. albicans) and Aspergillus niger (A. niger) 
using Griseofulvin as a standard. The results are 
shown in Table 1. 
Compared with Streptomycin sulphate the com-
pounds 5b and 5e–g showed moderate antibacterial 
activity against E. coli and 5b and 5f against S. 
aureus. Compared with the standard Griseofulvin 
the compounds 5b–c, 5e and 5f showed promising 








































































5a   R1 = R2 = R3 = H,
5b   R1 = -OCH3, R2 = R3 = H,
5c   R1 = R2 = -OCH3, R3 = H,
5d   R1 = R2 = R3 = -OCH3,
5e   R1 = Cl, R2 = R3 = H,
5f   R1 = -N(CH3)2, R2 = R3 = H,
5g   R1 = -CH3, R2 = R3 = H
 
Table 1. Antibacterial and antifungal activity of synthe-
sized pyrazole derivatives (5a–g). (Zone of inhibition in 
mm). 
Antibacterial activity Antifungal activity Compounds 
E. coli S. aureus C. albicans A. niger 
5a 08 10 06 06 
5b 12 12 08 06 
5c 10 08 08 04 
5d 10 08 06 04 
5e 12 10 08 06 
5f 14 12 10 08 
5g 12 10 06 04 
Streptomycin 
sulpate 
18 20 Not tested Not tested
Griseofulvin Not tested Not tested 14 12 
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EXPERIMENTAL SECTION 
The purity of all synthesized compounds was 
checked by thin layer chromatography using silica 
gel G. The final compounds were purified by 
column chromatography on silica gel (70–230 mesh, 
Merck) using mixture of chloroform:acetone (7:1) 
as eluent. 1H NMR spectra were registered either on 
a Bruker 300 MHz or Jeol 60 MHz Hitachi Perkin 
Elmer spectrometer, and 13C NMR spectra on a Jeol 
GSX 400 (75 MHz) instrument using 1% tetrame-
thylsilane in CDCl3 as an internal standard (chemical 
shifts are expressed in δ, ppm downfield from the 
tetramethylsilane). Mass spectra were obtained on 
an electron impact Maspec MSW 9629 spectrometer 
and important fragments are given with the relative 
intensities in brackets. 
Typical procedure for the preparation of ethyl 5-
methyl-1,3-diphenyl-1H-pyrazole-4-carboxylate (5a): 
A mixture of benzaldehyde hydrazone (1a, 2.35 g, 
12.0 mmol), excess of freshly distilled ethyl aceto-
acetate 3 (2.6 g, 20.0 mmol) and CAT (3.94 g, 14.0 
mmol) in glacial acetic acid (25 ml) were stirred at 
room temperature for 2–3 h. The progress of the 
reaction was monitored by TLC. After the comple-
tion of the reaction the residue was dissolved in 
ether (25 ml), washed successively with water (2 × 
20 ml), 1 N NaOH (1 × 10 ml), brine solution (2 × 
15 ml) and dried over Na2SO4. Evaporation of the 
solvent afforded crude oily substance. Purification 
was done by column chromatography using a mixture 
of dichloromethane:ethyl acetate (8:1) as eluent, 
which afforded 5a as light yellow oil in 80% yield 
(2.93 g). The pyrazole 5a showed IR bands (Nujol) 
ν: 1722 cm–1 (C=O), 1620 cm–1 (C=N), 1602 cm–1 
(C=C); 1H NMR (CDCl3) δ: 1.24 (t, 3H, J = 7.2 Hz, 
–OCH2–CH3), 2.72 (s, 3H, H3C–C(5)), 4.18 (q, 2H, 
J = 7.2 Hz, –OCH2–CH3), 7.05–7.26 (s, 5H, Ar’–H), 
7.65–7.78 (m, 5H, Ar”–H); 13C NMR (CDCl3) δ: 
0.92 (q, 1C, H3C–C(5)), 13.56 (q, 1C, –CH2–CH3), 
58.62 (t, 1C, –CH2–), 108.32 (s, 1C), 118.08 (d, 2C), 
124.42 (d, 1C), 124.56 (d, 2C), 126.22 (d, 2C), 
128.74 (d, 2C), 130.28 (s, 1C), 131.08 (d, 1C), 
132.42 (s, 1C), 161.12 (s, 1C), 176.22* (s, 1C, 5-C), 
174.88* (s, 1C, CO). MS (relative intensity) m/e for 
C19H18N2O2: 307 (M+1, 100), 277(31), 233 (38), 
218 (21), 194 (25), 112 (18), 103 (75), 91 (44), 88 
(10), 29(22). Anal. Calcd: C, 74.49; H, 5.92; N, 
9.14%. Found: C, 74.36; H, 5.72; N, 9.08%.  
Ethyl 3-(4-methoxyphenyl)-5-methyl-1-phenyl-1H-
pyrazole-4-carboxylate (5b): Obtained from 4-meth-
oxybenzaldehyde hydrazone 1b (2.71 g, 12 mmol), 
ethyl acetoacetate (2.6 g, 20.0 mmol) as an oily 
substance in 78% yield (3.14 g). IR bands (Nujol) ν: 
1716 cm–1 (C=O), 1618 cm–1 (C=N), 1596 cm–1 
(C=C); 1H NMR (CDCl3): δ 1.18 (t, 3H, J = 6.9 Hz, 
–OCH2–CH3), 2.75 (s, 3H, H3C–C(5)), 3.78 (s, 3H, 
–OCH3), 4.12 (q, 2H, J = 7.0 Hz, –OCH2–CH3), 
6.92 (d, 2H, Ar’–H), 7.22 (d, 2H, Ar’–H), 7.36–7.48 
(m, 5H, Ar”–H); 13C NMR (CDCl3) δ: 0.86 (q, 1C,  
H3C–C(5)), 13.54 (q, 1C, –CH2–CH3), 55.80 (q, 1C, 
4’–OCH3), 58.62 (t, 1C, –CH2–), 108.52 (s, 1C), 
118.18 (d, 2C), 122.56 (d, 2C), 124.88 (d, 1C), 
126.22 (d, 2C), 128.74 (d, 2C), 136.28 (s, 1C), 
131.08 (d, 1C), 132.42 (s, 1C), 160.82 (s, 1C), 
176.20* (s, 1C, 5-C), 171.68* (s, 1C, CO). MS 
(relative intensity) m/e for C20H20N2O3: 337 (M+1, 
100), 307(32), 263 (40), 248 (20), 224 (24), 112 
(16), 133 (78), 91 (46), 88 (10), 29(24). Anal. Calcd: 
C, 71.41; H, 5.99; N, 8.33%. Found: C, 71.38; H, 
5.87, N; 8.25%.  
Ethyl 3-(3,4-dimethoxyphenyl)-5-methyl-1-phenyl-
1H-pyrazole-4-carboxylate (5c). Obtained from 3,4-
dimethoxybenzaldehyde hydrazone 1c (2.56 g, 10 
mmol), ethyl acetoacetate (2.34 g, 18.0 mmol) as an 
oily substance in 82% yield (2.74 g). IR bands 
(Nujol) ν: 1720 cm–1 (C=O), 1622 cm–1 (C=N), 1596 
cm–1 (C=C); 1H NMR (CDCl3): δ 1.22 (t, 3H, J = 
7.0 Hz, –OCH2–CH3), 2.68 (s, 3H, H3C–C(5)), 3.75 
(s, 6H, –OCH3), 4.16 (q, 2H, J = 7.1 Hz, –OCH2–
CH3), 6.98–7.12 (m, 3H, Ar’–H), 7.48–7.66 (m, 5H, 
Ar”–H); 13C NMR (CDCl3) δ: 1.02 (q, 1C, H3C–
C(5)), 13.66 (q, 1C, –CH2–CH3), 55.76* (q, 1C, 4’–
OCH3), 55.84* (q, 1C, 3’–OCH3), 59.02 (t, 1C, –
CH2–), 108.86 (s, 1C), 118.28 (d, 2C), 122.52 (d, 
2C), 124.86 (d, 1C), 126.34 (d, 2C), 128.78 (d, 2C), 
136.36 (s, 1C), 131.12 (d, 1C), 132.44 (s, 1C), 
161.14 (s, 1C), 176.24* (s, 1C, 5-C), 171.72* (s, 1C, 
CO). MS (relative intensity) m/e for C21H22N2O4: 
367 (M+1, 100), 337(30), 293 (39), 278 (23), 254 
(28), 163 (76), 112 (14), 91 (46), 88 (12), 29(26). 
Anal. Calcd: C, 68.84; H, 6.05; N, 7.65%. Found: C, 
68.77; H, 5.96; N, 7.54%.  
Ethyl 5-methyl-1-phenyl-3-(3,4,5-trimethoxyphe-
nyl)-1H-pyrazole-4-carboxylate (5d). Obtained from 
3,4,5-trimethoxybenzaldehyde hydrazone 1d (2.86 
g, 10 mmol), ethyl acetoacetate (2.34 g, 18.0 mmol) 
as an oily substance in 81% yield (3.20 g). IR bands 
(Nujol) ν: 1718 cm–1 (C=O), 1620 cm–1 (C=N), 1600 
cm–1 (C=C); 1H NMR (CDCl3) δ: 1.26 (t, 3H, J = 7.1 
Hz, –OCH2–CH3), 2.70 (s, 3H, H3C–C(5)), 3.71 (s, 
9H, –OCH3), 4.22 (q, 2H, J = 7.2 Hz, –OCH2–CH3), 
6.96 (m, 2H, Ar’–H), 7.52–7.68 (m, 5H, Ar”–H); 
13C NMR (CDCl3) δ: 1.04 (q, 1C, H3C–C(5)), 13.62 
(q, 1C, –CH2–CH3), 56.6 (q, 2C, 3’,5’–OCH3), 58.4 
(q, 1C, 4’–OCH3), 59.22 (t, 1C, –CH2–), 108.66 (s, 
1C), 122.28 (d, 2C), 124.66 (d, 1C), 126.48 (d, 2C), 
128.56 (d, 2C), 136.54 (s, 1C), 131.24 (d, 1C), 
132.46 (s, 1C), 136.12 (d, 2C), 161.04 (s, 1C), 
176.22* (s, 1C, 5-C), 169.88* (s, 1C, CO). MS 
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(relative intensity) m/e for C22H24N2O5: 397 (M+1, 
100), 367(29), 323 (42), 308 (24), 284 (22), 193 
(76), 112 (21), 91 (46), 88 (14), 29(30). Anal. Calcd: 
C, 66.65; H, 6.10; N, 7.07%. Found: C, 66.56; H, 
5.98; N, 7.04%.  
Ethyl 3-(4-chlorophenyl)-5-methyl-1-phenyl-1H-
pyrazole-4-carboxylate (5e). Obtained from 4-chlo-
robenzaldehyde hydrazone 1e (2.76 g, 12 mmol), 
ethyl acetoacetate (2.6 g, 20.0 mmol) as an oily 
substance in 79% yield (3.21g). IR bands (Nujol) ν: 
1724 cm–1 (C=O), 1616 cm–1 (C=N), 1598 cm–1 
(C=C); 1H NMR (CDCl3) δ: 1.25 (t, 3H, J = 7.2 Hz, 
–OCH2–CH3), 2.74 (s, 3H, H3C–C(5)), 4.22 (q, 2H, 
J = 7.1 Hz, –OCH2–CH3), 6.98 (d, 2H, Ar’–H), 7.18 
(d, 2H, Ar’–H), 7.44–7.60 (m, 5H, Ar”–H); 13C 
NMR (CDCl3) δ: 1.02 (q, 1C, H3C–C(5)), 13.58 (q, 
1C, –CH2–CH3), 59.22 (t, 1C, –CH2–), 108.48 (s, 
1C), 123.36 (d, 2C), 124.36 (d, 1C), 127.22 (d, 2C), 
128.62 (d, 2C), 134.62 (d, 1C), 132.46 (s, 1C), 
136.12 (d, 2C), 138.14 (s, 1C), 161.84 (s, 1C), 
176.14* (s, 1C, 5-C), 169.88* (s, 1C, CO). MS 
(relative intensity) m/e for C19H17N2O2Cl: 341 
(M+1, 100), 311 (30), 267 (41), 252 (18), 228 (34), 
137 (76), 112 (16), 91 (42), 88 (12), 29(26). Anal. 
Calcd: C, 66.96; H, 5.03; N, 8.22%. Found: C, 
66.91; H, 4.90; N, 8.16%.  
Ethyl 3-(4-N,N-dimethylaminophenyl)-5-methyl-
1-phenyl-1H-pyrazole-4-carboxylate (5f). Obtained 
from 4-N,N-dimethylbenzaldehyde hydrazone 1f 
(2.86 g, 12 mmol), ethyl acetoacetate (2.6 g, 20.0 
mmol) as an oily substance in 78% yield (3.25 g). 
IR bands (Nujol) ν: 1728 cm–1 (C=O), 1624 cm–1 
(C=N), 1602 cm–1 (C=C); 1H NMR (CDCl3) δ: 1.28 
(t, 3H, J = 6.9 Hz, –OCH2–CH3), 2.68 (s, 3H,  
H3C–C(5)), 2.98 (s, 6H, –N(CH3)2), 4.31 (q, 2H, J = 
6.8 Hz, –OCH2–CH3), 7.08 (d, 2H, Ar’–H), 7.24 (d, 
2H, Ar’–H), 7.48–7.66 (m, 5H, Ar”–H); 13C NMR 
(CDCl3) δ: 1.04 (q, 1C, H3C–C(5)), 13.62 (q, 1C,  
–CH2–CH3), 44.36 (q, 2C, –N(CH3)2), 59.28 (t, 1C,  
–CH2–), 108.38 (s, 1C), 123.16 (d, 2C), 124.30 (d, 
1C), 127.44 (d, 2C), 128.56 (d, 2C), 130.04 (d, 2C), 
132.46 (s, 1C), 134.78 (d, 1C), 138.24 (s, 1C), 
161.12 (s, 1C), 176.26* (s, 1C, 5-C), 169.36* (s, 1C, 
CO). MS (relative intensity) m/e for C21H23N3O2: 
350 (M+1, 100), 320 (28), 276 (42), 261 (22), 237 
(26), 146 (74), 112 (22), 91 (40), 88 (14), 29(30). 
Anal. Calcd: C, 72.18; H, 6.63; N, 12.03%. Found: 
C, 72.12; H, 6.51; N, 11.96%.  
Ethyl 5-methyl-1-phenyl-3-p-tolyl-1H-pyrazole-
4-carboxylate (5g). Obtained from 4-methylbenz-
aldehyde hydrazone 1g (2.10 g, 10 mmol), ethyl 
acetoacetate (2.08 g, 16.0 mmol) as an oily sub-
stance in 80% yield (2.56 g). IR bands (Nujol) ν: 
1726 cm–1 (C=O), 1626 cm–1 (C=N), 1598 cm–1 
(C=C); 1H NMR (CDCl3) δ: 1.30 (t, 3H, J = 6.7 Hz, 
–OCH2–CH3), 2.16 (s, 3H, H3C–C(5)), 2.72 (s, 3H, 
–CH3), 4.26 (q, 2H, J = 6.8 Hz, –OCH2–CH3), 7.06 
(d, 2H, Ar’–H), 7.28 (d, 2H, Ar’–H), 7.42–7.64 (m, 
5H, Ar”–H); 13C NMR (CDCl3) δ: 0.96 (q, 1C,  
H3C–C(5)), 13.58 (q, 1C, –CH2–CH3), 21.06 (q, 3H, 
H3C–C(4’)), 59.08 (t, 1C, –CH2–), 108.44 (s, 1C), 
124.04 (d, 2C), 124.44 (d, 1C), 127.66 (d, 2C), 
128.58 (d, 2C), 130.18 (d, 2C), 132.52 (s, 1C), 
134.86 (d, 1C), 138.32 (s, 1C), 161.02 (s, 1C), 
176.16* (s, 1C, 5-C), 169.22* (s, 1C, CO). MS 
(relative intensity) m/e for C20H20N2O2: 321 (M+1, 
100), 291(30), 247 (40), 232 (22), 208 (26), 164 
(78), 112 (18), 91 (42), 88 (12), 29(26). Anal. Calcd: 
C, 74.98; H, 6.29; N, 8.74%. Found: C, 74.92; H, 
6.17; N, 8.66%. 
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(Резюме) 
Етилацетоацетат реагира с нитрилимини получени in situ чрез каталитично дехидрогениране на дифенил-
хидразон в присъствие на хлорамин-Т (САТ) до получаване на съответни региоселективни циклоадукти с добив 
80%. Структурата на тези съединения е охарактеризирана с ИЧС, 1Н ЯМР, 13С ЯМР, масспектрометрия и 
елементен анализ. Всички пиразолови производни са изпитани за техните антибактериална и антигъбична 
активности. 
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